Scientific Publications

Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial

B.A.C. Cree
H.J. Kim
B.G. Weinshenker
S.J. Pittock
D.M. Wingerchuk
K. Fujihara
F. Paul
G.R. Cutter
R. Marignier
A.J. Green
O. Aktas
H.P. Hartung
D. She
W. Rees
M. Smith
D. Cimbora
E. Katz
J.L. Bennett

Establishment of a high-content compatible platform to assess effects of monocyte-derived factors on neural stem cell proliferation and differentiation

J. Campo Garcia
R.J. Bueno
M. Salla
I. Martorell-Serra
B. Seeger
N. Akbari
P. Sperber
H. Stachelscheid
C. Infante-Duarte
F. Paul
S.C. Starossom

Clinical characterization and ancillary tests in Susac syndrome: a systematic review

A. Wilf-Yarkoni
O. Zmira
A. Tolkovsky
B. Pflantzer
S.G. Gofrit
I. Kleffner
F. Paul
J. Dörr

An exploratory research report on brain mineralization in postoperative delirium and cognitive decline

F. Lammers-Lietz
F. Borchers
I. Feinkohl
S. Hetzer
C. Kanar
F. Konietschke
G. Lachmann
C. Chien
C. Spies
G. Winterer
L. Zaborszky
N. Zacharias
F. Paul

Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity - a potential diagnostic pitfall in patients with MOG-EM/MOGAD

S. Jarius
M. Ringelstein
K. Schanda
K. Ruprecht
M. Korporal-Kuhnke
A. Viehöver
M.W. Hümmert
P. Schindler
V. Endmayr
M. Gastaldi
C. Trebst
D. Franciotta
O. Aktas
R. Höftberger
J. Haas
L. Komorowski
F. Paul
M. Reindl
B. Wildemann

Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis

L. Meyer-Arndt
J. Brasanac
S. Gamradt
J. Bellmann-Strobl
L. Maurer
K. Mai
T. Steward
J. Spranger
T. Schmitz-Hübsch
F. Paul
S.M. Gold
M. Weygandt

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD

A. Duchow
J. Bellmann-Strobl
T. Friede
O. Aktas
K. Angstwurm
I. Ayzenberg
A. Berthele
E. Dawin
D. Engels
K. Fischer
M. Flaskamp
K. Giglhuber
M. Grothe
J. Havla
M.W. Hümmert
S. Jarius
M. Kaste
P. Kern
I. Kleiter
L. Klotz
M. Korporal-Kuhnke
M. Kraemer
M. Krumbholz
T. Kümpfel
L. Lohmann
M. Ringelstein
P. Rommer
P. Schindler
C. Schubert
C. Schwake
M. Senel
F.T. Bergh
D. Tkachenko
H. Tumami
C. Trebst
I. Vardakas
A. Walter
C. Warnke
M.S. Weber
J. Wickel
B. Wildemann
A. Winkelmann
F. Paul
J.P. Stellmann
V. Häußler

CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis

F. Cortes-Figueiredo
S. Asseyer
C. Chien
H.G. Zimmermann
K. Ruprecht
T. Schmitz-Hübsch
J. Bellmann-Strobl
F. Paul
V.A. Morais

The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis

T.J. Hartung
G. Cooper
V. Jünger
D. Komnenić
L. Ryan
J. Heine
C. Chien
F. Paul
H. Prüss
C. Finke

March 01, 2024 / Sci Transl Med

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories

C.C. Gross
A. Schulte-Mecklenbeck
O.V. Steinberg
T. Wirth
S. Lauks
S. Bittner
P. Schindler
S.E. Baranzini
S. Groppa
J. Bellmann-Strobl
N. Bünger
C. Chien
E. Dawin
M. Eveslage
V. Fleischer
G. Gonzalez-Escamilla
B. Gisevius
J. Haas
M. Kerschensteiner
L. Kirstein
C. Korsukewitz
L. Lohmann
J.D. Lünemann
F. Luessi
G. Meyer Zu Hörste
J. Motte
T. Ruck
K. Ruprecht
N. Schwab
F. Steffen
S.G. Meuth
F. Paul
B. Wildemann
T. Kümpfel
R. Gold
T. Hahn
F. Zipp
L. Klotz
H. Wiendl